Publications by authors named "Gabriel Areoye"
Article Synopsis
- Protein-energy malnutrition (PEM) increases the mortality risk and health care costs for patients hospitalized with atrial fibrillation (AF), a condition often linked to chronic inflammation.
- In a study involving over 821,000 AF hospitalizations, 3% had PEM, leading to a significant increase in hospital length of stay, costs, and complications like cardiogenic shock.
- Results suggest that addressing PEM through nutritional rehabilitation may improve clinical outcomes for AF patients, highlighting the importance of nutrition in managing chronic diseases.
Background Non-alcoholic fatty liver disease (NAFLD), one of the leading causes of end-stage liver disease, is known to be associated with obesity. However, only a few studies in the United States (US) have described non-obese NAFLD, most of which were on the outpatient population. Aim We aimed to investigate the proportion of hospitalizations in the US with a diagnosis code that included NAFLD in the non-obese population.
View Article and Find Full Text PDFBACKGROUND Paravalvular leaks (PVL) are becoming more commonly experienced in clinical practice due to the increasing number of mitral valve replacements performed. There are about 182 000 valve replacements performed annually, with a 5-15% prevalence rate of paravalvular leaks. Due to increased mortality associated with surgical repair, percutaneous transcatheter closure procedures are increasingly being performed as an alternative to repeat surgery.
View Article and Find Full Text PDFSweet's syndrome in a granulocytopenic patient with acute myeloid leukemia on FLT3 inhibitor.
J Community Hosp Intern Med Perspect
June 2020
Article Synopsis
- Gilteritinib is a medication used to treat acute myeloid leukemia (AML) with specific FLT3 mutations, but it can lead to complications like febrile neutropenia and Sweet's syndrome (SS).
- A case study highlights a 55-year-old woman who developed fever and skin lesions after starting Gilteritinib, which were linked to her low neutrophil count and improved temporarily with prednisone.
- Despite stopping Gilteritinib due to the rash, the patient ultimately faced severe disease progression and sepsis, emphasizing the need for clinicians to recognize potential skin issues related to FLT3 inhibitors, even in neutropenic patients.